| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4: Prudo-Chlebosz Raymond, Director
Received 9,072 shares as a grant or award ($71.7K) · Granted 45,000 Stock Option (Right to Buy) · Received 3,240 shares as a grant or award ($25.6K) |
| 16 Oct 2026 |
Form 4: Huh Hoyoung, Director
Received 17,249 shares as a grant or award ($136K) · Granted 45,000 Stock Option (Right to Buy) · Received 6,160 shares as a grant or award ($48.7K) |
| 16 Oct 2026 |
Form 4: Patel Sandip I, Director
Received 12,100 shares as a grant or award ($95.6K) · Granted 60,000 Stock Option (Right to Buy) · Received 4,313 shares as a grant or award ($34.1K) · 1 more |
| 16 Oct 2026 |
Form 4: Bazemore Robert B, Director
Received 13,100 shares as a grant or award ($103K) · Granted 60,000 Stock Option (Right to Buy) · Received 4,677 shares as a grant or award ($36.9K) · 1 more |
| 16 Oct 2026 |
Form 4: Gaslightwala Abizer, Director
Granted 174,000 Stock Option (Right to Buy) · Received 27,066 shares by exercise or conversion ($10.8) |
| 16 Oct 2026 |
Form 4: Patel Samir Rashmikant, Director
Received 6,300 shares as a grant or award ($49.8K) · Granted 45,000 Stock Option (Right to Buy) · Received 2,236 shares as a grant or award ($17.7K) |
| 14 Oct 2026 |
Form 4: Vat-Ho Vatnak, Chief Business Officer
Granted 87,000 Stock Option (Right to Buy) |
| 14 Oct 2026 |
Form 3: Vat-Ho Vatnak, Chief Business Officer
No securities owned |
| 01 Oct 2026 |
Form 4: Gaslightwala Abizer, Director
Received 6,430 shares as a grant or award ($62.5K) |
| 01 Oct 2026 | Proxy statement: annual meeting on October 28, 2026 |
| 01 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
This AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into as of September 29, 2026, by and between Akari Therapeutics, Plc (the “Company”) and you, Abizer Gaslightwala (individually, a “Party,” and collectively, the “Part... |
| 19 Aug 2026 |
Form 4: Farag Kameel D., Interim CFO
Received 1,728 shares as a grant or award ($13K) |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Aug 2026 | SCHEDULE 13G |
| 07 Aug 2026 | SCHEDULE 13G |
| 05 Aug 2026 |
Form 4: Farag Kameel D., Interim CFO
Received 1,130 shares as a grant or award ($13K) |
| 17 Jul 2026 |
Form 4: Patel Samir Rashmikant, Director
Received 22,474 shares by exercise or conversion ($9.68K) · Acquired 1,209 Pre-Funded Warrant to purchase American Depositary Shares (Option Exercise/Conversion) ($38.7K) · Acquired 21,265 Pre-Funded Warrant to purchase ADSs (Option Exercise/Conversion) ($344K) |
| 13 Jul 2026 | EFFECT |
| 10 Jul 2026 | S-3/A |
Loading...